Bank Of Montreal Iovance Biotherapeutics, Inc. Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$5.53 - $8.22 $5.23 Million - $7.77 Million	945,516 New	945,516 $5.78 Million
Q4 2022 Feb 01, 2023	BUY	$5.62 - $10.0 $5.79 Million - $10.3 Million	1,029,815 Added 151.98%	1,707,394 $10.9 Million
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $6.46 Million - $8.88 Million	677,579 New	677,579 $6.69 Million
Q2 2022 Aug 11, 2022	SELL	$6.38 - $18.33 $1.47 Million - $4.21 Million	-229,734 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$12.38 - $19.1 $1.25 Million - $1.92 Million	100,671 Added 78.0%	229,734 $3.84 Million
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $2.14 Million - $3.57 Million	129,063 New	129,063 $2.51 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $2.73 Million - $3.57 Million	-134,046 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$16.33 - $33.07 $2.19 Million - $4.43 Million	134,046 New	134,046 $3.55 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.21B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.